2-(4-oxo-3-Phenyl-1,3-selenazolidin-2-ylidene)malononitrile

Catalog No. :
ACMLXS136
CAS No. :
887000-70-6
Molecular Formula :
C12H7N3OSe
Molecular Weight :
288.17

IUPAC Name:2-(4-oxo-3-phenyl-1,3-selenazolidin-2-ylidene)malononitrile

2-(4-oxo-3-Phenyl-1,3-selenazolidin-2-ylidene)malononitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$183.00Login to see priceInquiryInquiry
250mg95%$298.00Login to see priceInquiryInquiry
1g95%$733.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-oxo-3-Phenyl-1,3-selenazolidin-2-ylidene)malononitrile
IUPAC Name2-(4-oxo-3-phenyl-1,3-selenazolidin-2-ylidene)malononitrile
MDL No.MFCD30475787
Molecular FormulaC12H7N3OSe
Molecular Weight288.17
SMILESN#CC(C#N)=C(N1C2=CC=CC=C2)[Se]CC1=O
InChI KeyICQPGYKDMZBXST-UHFFFAOYSA-N
SynonymPropanedinitrile,2-(4-oxo-3- phenyl-2-selenazolidinylidene)-;PROPANEDINITRILE,2-(4-OXO-3-PHENYL-2-SELENAZOLIDINYLIDENE)-;2-(4-oxo-3-Phenyl-1,3-selenazolidin-2-ylidene)malononitrile;2-(4-Oxo-3-phenyl-2-selenazolidinylidene)propanedinitrile
CAS No.887000-70-6

Safety Data

Pictogram
ToxicHealth hazardEnvironmental hazard
Signal Word
Gefahr
Hazard Statement(s)
H331-H373-H410
Precautionary Statement(s)
P260-P264-P270-P271-P273-P301+P310+P330-P304+P340+P311-P314-P391-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACMLXS136 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMLXS136 route product structure diagram
    ACMLXS136887000-70-6
Inquiry

2. ACMLXS136 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMLXS136 route product structure diagram
    ACMLXS136887000-70-6
Inquiry

Comments (0)